What is the address of Dr. Evert Baten, uroloog?

The registered office of Dr. Evert Baten, uroloog is located at Kapellekensweg 10, 3010 Leuven.

Is Dr. Evert Baten, uroloog still active?

Yes. According to the CBE (2 October 2026) Dr. Evert Baten, uroloog is active, legal situation “Normale toestand”, started on 22 July 2019.

Is Dr. Evert Baten, uroloog registered on Peppol?

No, Dr. Evert Baten, uroloog is currently not registered on the Peppol network.

What is the enterprise number of Dr. Evert Baten, uroloog?

The enterprise number of Dr. Evert Baten, uroloog is BE0730919843.

When was Dr. Evert Baten, uroloog founded?

Dr. Evert Baten, uroloog was founded on 22 July 2019.

Who are the directors of Dr. Evert Baten, uroloog?

According to the 2025 annual accounts, the directors of Dr. Evert Baten, uroloog are: Evert Baten.

Is Dr. Evert Baten, uroloog a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 22 July 2019; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Evert Baten, uroloog make in 2025?

Dr. Evert Baten, uroloog posted a profit after taxes of € 314,233 in financial year 2025.

What is the revenue of Dr. Evert Baten, uroloog?

As a small company, Dr. Evert Baten, uroloog is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 419,713.

Dr. Evert Baten, uroloog (Private Limited) - Leuven

Dossier Dr. Evert Baten, uroloog, printed on 2 October 2026 from databakkes.be/en/0730919843/dr-evert-baten-uroloog. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 45 % of short-term debt in 2025; threshold 65 %.
Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

Dr. Evert Baten, uroloog from Leuven, company number BE0730919843, closed financial year 2025 with a result of € 314,233 after tax. For that financial year Dr. Evert Baten, uroloog recorded a gross margin of € 419,713 and equity of € 5,000. Compared with financial year 2024, the result moved from € 308,973 to € 314,233. Profitable, and profit is growing. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 22, 2026.

What it is worth Healthy

€ 5,000

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 314,233

▲ 2% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 146,371

▲ 6% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 314,233 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 7,906

▲ 22% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 3,212

▲ 2% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 865

▼ 96% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 284,400 Gross margin 2022: € 284,400 First fiscal year in the series	€ 330,580 Gross margin 2023: € 330,580 ▲ 16% vs 2022 (€ 284,400) Favourable step	€ 412,849 Gross margin 2024: € 412,849 ▲ 25% vs 2023 (€ 330,580) Favourable step	€ 419,713 Gross margin 2025: € 419,713 ▲ 2% vs 2024 (€ 412,849) Favourable step	▲ 2%
Profit after taxes	€ 211,242 Profit after taxes 2022: € 211,242 First fiscal year in the series	€ 243,552 Profit after taxes 2023: € 243,552 ▲ 15% vs 2022 (€ 211,242) Favourable step	€ 308,973 Profit after taxes 2024: € 308,973 ▲ 27% vs 2023 (€ 243,552) Favourable step	€ 314,233 Profit after taxes 2025: € 314,233 ▲ 2% vs 2024 (€ 308,973) Favourable step	▲ 2%
Equity	€ 216,662 Equity 2022: € 216,662 First fiscal year in the series	€ 5,000 Equity 2023: € 5,000 ▼ 98% vs 2022 (€ 216,662) Unfavourable step	€ 5,000 Equity 2024: € 5,000 Unchanged (€ 5,000) Unchanged	€ 5,000 Equity 2025: € 5,000 Unchanged (€ 5,000) Unchanged
Total debts	€ 79,038 Total debts 2022: € 79,038 First fiscal year in the series	€ 303,936 Total debts 2023: € 303,936 ▲ 285% vs 2022 (€ 79,038) Unfavourable step	€ 358,785 Total debts 2024: € 358,785 ▲ 18% vs 2023 (€ 303,936) Unfavourable step	€ 337,201 Total debts 2025: € 337,201 ▼ 6% vs 2024 (€ 358,785) Favourable step	▼ 6%
Cash	€ 148,357 Cash 2022: € 148,357 First fiscal year in the series	€ 146,353 Cash 2023: € 146,353 ▼ 1% vs 2022 (€ 148,357) Unfavourable step	€ 138,717 Cash 2024: € 138,717 ▼ 5% vs 2023 (€ 146,353) Unfavourable step	€ 146,371 Cash 2025: € 146,371 ▲ 6% vs 2024 (€ 138,717) Favourable step	▲ 6%
Retained profit	€ 211,662 Retained profit 2022: € 211,662 First fiscal year in the series	€ 0 Retained profit 2023: € 0 ▼ 100% vs 2022 (€ 211,662) Unfavourable step	€ 0 Retained profit 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Retained profit 2025: € 0 Unchanged (€ 0) Unchanged
Dividend	€ 195,000 Dividend 2022: € 195,000 First fiscal year in the series	€ 455,214 Dividend 2023: € 455,214 ▲ 133% vs 2022 (€ 195,000) Unchanged	€ 308,973 Dividend 2024: € 308,973 ▼ 32% vs 2023 (€ 455,214) Unchanged	€ 314,233 Dividend 2025: € 314,233 ▲ 2% vs 2024 (€ 308,973) Unchanged	▲ 2%
Balance sheet total	€ 295,700 Balance sheet total 2022: € 295,700 First fiscal year in the series	€ 308,936 Balance sheet total 2023: € 308,936 ▲ 4% vs 2022 (€ 295,700) Unchanged	€ 363,785 Balance sheet total 2024: € 363,785 ▲ 18% vs 2023 (€ 308,936) Unchanged	€ 342,201 Balance sheet total 2025: € 342,201 ▼ 6% vs 2024 (€ 363,785) Unchanged	▼ 6%

Key figures of Dr. Evert Baten, uroloog, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Evert Baten, uroloog?

What happened at Dr. Evert Baten, uroloog in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 22, 2026 New annual accounts for financial year 2025: profit of € 314,233 (▲ 2% vs 2024). Source: NBB ↗
Jul 22, 2019 New establishment in Leuven. KBO
2019 Evert Baten became a director. NBB
Jul 22, 2019 Start of the company according to the CBE. KBO

In short

From € 211,242 profit in 2022 to € 314,233 profit in 2025.

Paid € 339,873 in corporate taxes since 2022.

Best year ever: 2025, with € 314,233 profit.

Paid out € 1.3 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Evert Baten, uroloog? We notify you, reason included.

Follow Dr. Evert Baten, uroloog

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Evert Baten

Dr. Evert Baten, uroloog

Behind Dr. Evert Baten, uroloog is Evert Baten.

See the full network in the app

Directors

According to the 2025 annual accounts

Evert Baten

Director

since 2019

Establishments

Establishment units

Physical locations of this company

Registered office

Kapellekensweg 10

3010 Leuven

2.291.508.402

Heidebergstraat 150

3010 Leuven

Active since 22 July 2019

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0730.919.843
VAT number: BE 0730.919.843
Registered office: Kapellekensweg 10, 3010 Leuven
Names & denominations: Dr. Evert Baten, uroloog
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 22 July 2019
Peppol: Not registered
Contact: [email protected]

View on CBE Public ↗ Annual accounts (NBB) ↗